BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37196346)

  • 21. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
    Adejoro O; Alishahi A; Konety B
    Urology; 2016 Nov; 97():130-137.e1. PubMed ID: 27397095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.
    Warschkow R; Güller U; Cerny T; Schmied BM; Plasswilm L; Putora PM
    Radiother Oncol; 2017 Apr; 123(1):139-146. PubMed ID: 28285840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
    J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
    Hoffman KE; Hong TS; Zietman AL; Russell AH
    Cancer; 2008 Feb; 112(4):943-9. PubMed ID: 18098220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality.
    Keehn A; Ludmir E; Taylor J; Rabbani F
    World J Urol; 2017 May; 35(5):713-720. PubMed ID: 27629559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
    Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
    Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of population-based bladder cancer registries: How criteria heterogeneity affects the comparison of incidences.
    Caballero JM; Gili JM; Pereira JC; Gomáriz A; Castillo C; Martín-Baranera M
    Cancer Med; 2023 Mar; 12(6):7540-7551. PubMed ID: 36530046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of second malignancies for prostate cancer.
    Van Hemelrijck M; Feller A; Garmo H; Valeri F; Korol D; Dehler S; Rohrmann S
    PLoS One; 2014; 9(7):e102596. PubMed ID: 25047238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort.
    Schulz GB; Grimm T; Buchner A; Jokisch F; Kretschmer A; Stief CG; Knüchel R; Kraywinkel K; Karl A
    Clin Genitourin Cancer; 2020 Jun; 18(3):162-170.e4. PubMed ID: 31956010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple primary tumors following stage II and III rectal cancer in patients receiving radiotherapy, 1998-2010.
    Smith-Gagen J; Goodwin GA; Tay J
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):949-55. PubMed ID: 24663823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study.
    Guan X; Wei R; Yang R; Lu Z; Liu E; Zhao Z; Chen H; Yang M; Liu Z; Jiang Z; Wang X
    Front Oncol; 2020; 10():586401. PubMed ID: 33569344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database.
    Maruf M; Sidana A; Purnell S; Jain AL; Brancato SJ; Agarwal PK
    Int Urol Nephrol; 2018 Feb; 50(2):257-262. PubMed ID: 29275528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
    Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000.
    Pickles T; Phillips N
    Radiother Oncol; 2002 Dec; 65(3):145-51. PubMed ID: 12464442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer.
    Zelefsky MJ; Housman DM; Pei X; Alicikus Z; Magsanoc JM; Dauer LT; St Germain J; Yamada Y; Kollmeier M; Cox B; Zhang Z
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):953-9. PubMed ID: 22172904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a case-mix approach to study the trends in the incidence of second primary cancers.
    Gass B; Marrer E; Bara S; Ligier K; Molinié F; Colonna M; Daubisse-Marliac L; Trétarre B; Lapôtre-Ledoux B; Woronoff AS; Guizard AV; Bouvier V; Troussard X; Gaiddon C; Klein D; Velten M; Jégu J
    Ann Epidemiol; 2018 May; 28(5):322-327. PubMed ID: 29550348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Population-Based Study of Secondary Prostate Cancer Risk after Radiotherapy in Male Patients with Rectal Cancer: A Retrospective Cohort Study.
    Chuang JP; Lee YC; Lee JC; Lu CL; Li CY
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31013982
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
    Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
    Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.